SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000880771-15-000034
Filing Date
2015-03-18
Accepted
2015-03-18 16:59:06
Documents
1
Period of Report
2015-03-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT rivet-form4.html 4  
1 PRIMARY DOCUMENT rivet-form4.xml 4 6711
  Complete submission text file 0000880771-15-000034.txt   8113
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Issuer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 29F SHANGHAI TIMES SQUARE NO. 93 HUAI HAI ZHONG ROAD SHANGHAI F4 200021
Business Address
Xie Lan (Reporting) CIK: 0001555794 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19825 | Film No.: 15710672